Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pharmaxis Ltd ( (AU:SNT) ) just unveiled an announcement.
Syntara Limited has announced the quotation of 539,000 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of June 10, 2025. This move reflects the company’s ongoing efforts to enhance its market presence and provide liquidity to its shareholders, potentially impacting its market positioning and stakeholder relations positively.
The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.25 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.
More about Pharmaxis Ltd
Average Trading Volume: 8,091,739
Technical Sentiment Signal: Buy
Current Market Cap: A$112.1M
Learn more about SNT stock on TipRanks’ Stock Analysis page.